Tregs accumulate in melanoma, which also exhibit an enrichment of activated CD8+ T-cells [103] and the ratio of CD8-positive T cells versus Treg has been found to be a predictor for melanoma patient survival [104]. This evidence concerns the gene CD8A and melanoma.